SBRT
Completed
98 enrolled
EARN
Phase NA Completed
33 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
PREFER
Completed
1,429 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Phase 1 Completed
37 enrolled
ROOT
Completed
167 enrolled
IVY
Phase 1 Completed
353 enrolled
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Phase 1 Completed
110 enrolled
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Phase 4 Completed
337 enrolled 8 charts
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
Phase 2 Completed
37 enrolled 13 charts
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Phase 2 Completed
730 enrolled 25 charts
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Phase NA Completed
41 enrolled
ASPIRE
Phase NA Completed
340 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
A Study of PNT2258 in Patients With Advanced Solid Tumors
Phase 1 Completed
22 enrolled
DUET-4
Phase 1 Completed
78 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
DUET-2
Phase 1 Completed
150 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
VAPOR-C
Phase 4 Completed
169 enrolled
LiPlaCis
Phase 1/2 Completed
50 enrolled
Safety Study of MGA271 in Refractory Cancer
Phase 1 Completed
179 enrolled
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
Phase NA Completed
14 enrolled
Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors
Phase 1/2 Completed
62 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
Phase 1/2 Completed
9 enrolled
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
PSX-X04
Phase 1 Completed
8 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs
Phase NA Completed
20 enrolled
EPAC
Phase NA Completed
213 enrolled 20 charts
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
Phase NA Completed
39 enrolled 15 charts
CTC
Completed
150 enrolled
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Phase NA Completed
322 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Phase 1 Completed
18 enrolled
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
19 enrolled
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Phase 1 Completed
180 enrolled
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase 2 Completed
51 enrolled 6 charts